Dendritic cells of the mouse recognized by two monoclonal antibodies
โ Scribed by Matthijs Breel; Reina E. Mebius; Georg Kraal
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 707 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
โฆ Synopsis
A new monoclonal antibody, MIDC-8, is described which shows a comparable tissue distribution as the recently described NLDC-145 antibody. It recognizes interdigitating cells, veiled cells and Langerhans cells in lymphoid organs and the skin of the mouse. In contrast to NLDC-145 it recognizes a cytoplasmic component of these cell types. Its distribution is more restricted to the T cell-dependent areas than NLDC-145. Isolation of dendritic cells from lymph nodes, spleen and thymus revealed that both antibodies react with the in vitro isolated dendritic cells. The results show that these antibodies can be used to study dendritic cells in vitro and emphasize the relationship between the in vivo interdigitating cells of the T cell areas and the in vitro isolated dendritic cells.
๐ SIMILAR VOLUMES
Characteristics and functional aspects of nonlymphoid cells in rat germinal centers, recognized by two monoclonal
## Background: In the chicken, circulating antigens enter the splenic white pulp via the schweigger-seidel sheaths (ellipsoids), where they are bound by cells, the ellipsoid associated cells (eac), which are located on the periphery of the ellipsoid. there is an increasing body of evidence that the
A rat monoclonal antibody, YBMi42, directed against mouse leukocyte common antigen, was used for the analysis and separation of hemopoietic progenitor cells from mouse bone marrow and fetal liver. Cells were fractionated o n a FACS-II cell sorter and the resulting subpopulations examined for their m
## Bi -specific monoclonal antibodies (MAbs) were developed by somatic hybridization of 2 mouse hybridomas, one producing MAb against the G250 renal-cell carcinoma (RCC)-associated antigen and the other against the T-cell antigen CD3 (OKT3). The dual specificity of the hybrid MAb produced by these